Lexaria Bioscience Corp (LEXX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 11-2019 | 08-2019 | 05-2019 | 02-2019 | 11-2018 | |
| Sales | 10 | 125 | 60 | 15 | 22 |
| Cost of Goods | 8 | 15 | 3 | 3 | 2 |
| Gross Profit | 3 | 110 | 57 | 13 | 20 |
| Operating Expenses | 779 | 840 | 881 | 839 | 525 |
| Operating Income | -769 | -715 | -821 | -823 | -503 |
| Other Income | -207 | -402 | -367 | -330 | -198 |
| Pre-tax Income | -976 | -1,116 | -1,188 | -1,153 | -701 |
| Net Income Continuous | -976 | -1,116 | -1,188 | -1,153 | -701 |
| Net Income Discontinuous | 51 | N/A | N/A | N/A | N/A |
| Net Income | $-925 | $-1,116 | $-1,188 | $-1,153 | $-701 |
| EPS Basic Total Ops | -0.33 | -0.60 | -0.30 | -0.30 | -0.30 |
| EPS Basic Continuous Ops | -0.35 | -0.44 | -0.44 | -0.45 | -0.28 |
| EPS Basic Discontinuous Ops | 0.02 | N/A | N/A | N/A | N/A |
| EPS Diluted Total Ops | -0.33 | -0.60 | -0.30 | -0.30 | -0.30 |
| EPS Diluted Continuous Ops | -0.35 | -0.44 | -0.44 | -0.45 | -0.28 |
| EPS Diluted Discontinuous Ops | 0.02 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-741 | $-688 | $-799 | $-813 | $-501 |